ERBB2 and breast cancer: In addition, 3-Phenylquinolinylchalcone derivatives triggered antiproliferative activities and G2/M arrest in the non-small cell lung cancer (H1299) and HER2-positive breast cancer cells (SKBR-3), which is in concordance with our data [33].